Linear and cyclic melanocortin receptor-specific peptides
US7417027B2 · kind B2 · utility
12Cited by
7References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2004 |
| Grant date | Aug 26, 2008 |
| Priority date | — |
| Expiry date | Aug 4, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Linear and cyclic peptides are provided specific to one or melanocortin receptors, and which exhibit agonist, antagonist, or mixed agonist-antagonist activity. In one embodiment, a linear peptide of the following general formula is provided:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.